Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Amending Poultry Broiler Litter to Prevent the Development of Stable Fly, Stomoxys calcitrans (Diptera: Muscidae) and Other Nuisance Flies.

Cook DF, Jenkins SN, Abbott LK, D'Antuono MF, Telfer DV, Deyl RA, Lindsey JB.

J Econ Entomol. 2018 Sep 26. doi: 10.1093/jee/toy277. [Epub ahead of print]

PMID:
30256976
2.

Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year.

Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, Cutlip DE, Kleiman NS; Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Investigators.

Circ Cardiovasc Interv. 2012 Dec;5(6):772-82. doi: 10.1161/CIRCINTERVENTIONS.111.967802. Epub 2012 Oct 23.

PMID:
23093553
3.

Mode of death after contemporary percutaneous coronary intervention: a report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.

Stolker JM, Cohen DJ, Lindsey JB, Kennedy KF, Kleiman NS, Marso SP.

Am Heart J. 2011 Nov;162(5):914-21. doi: 10.1016/j.ahj.2011.08.014.

PMID:
22093209
4.

Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry.

Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ.

Circ Cardiovasc Interv. 2011 Oct 1;4(5):474-80. doi: 10.1161/CIRCINTERVENTIONS.111.962233. Epub 2011 Oct 4.

PMID:
21972402
5.

Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.

Venkitachalam L, Lei Y, Stolker JM, Mahoney EM, Amin AP, Lindsey JB, Kennedy KF, Pencina MJ, Lopez JJ, Kleiman NS, Cohen DJ; EVENT Registry Investigators.

Circulation. 2011 Aug 30;124(9):1028-37. doi: 10.1161/CIRCULATIONAHA.110.978593. Epub 2011 Aug 15.

PMID:
21844081
6.

Tissue characterisation of atherosclerotic plaque in the left main: an in vivo intravascular ultrasound radiofrequency data analysis.

Mercado N, Moe TG, Pieper M, House JA, Dolla WJ, Seifert L, Stolker JM, Lindsey JB, Kennedy KF, Marso SP.

EuroIntervention. 2011 Jul;7(3):347-52. doi: 10.4244/EIJV7I3A59.

7.

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2: 3 liraglutide clinical development studies.

Marso SP, Lindsey JB, Stolker JM, House JA, Martinez Ravn G, Kennedy KF, Jensen TM, Buse JB.

Diab Vasc Dis Res. 2011 Jul;8(3):237-40. doi: 10.1177/1479164111408937. Epub 2011 Jun 8.

PMID:
21653676
8.

Comparison of bleeding complications using arterial closure device versus manual compression by propensity matching in patients undergoing percutaneous coronary intervention.

Allen DS, Marso SP, Lindsey JB, Kennedy KF, Safley DM.

Am J Cardiol. 2011 Jun 1;107(11):1619-23. doi: 10.1016/j.amjcard.2011.01.049. Epub 2011 Mar 21.

PMID:
21420052
9.

In-hospital outcomes and cost comparison of femoropopliteal reopening strategies.

Safley DM, Lindsey JB, Robertus K, House JA, Mahoney E, Allen KB, Cohen DJ.

Cardiovasc Revasc Med. 2011 Sep-Oct;12(5):292-8. doi: 10.1016/j.carrev.2010.12.003. Epub 2011 Jan 26.

PMID:
21273148
10.

Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry.

Stolker JM, Kennedy KF, Lindsey JB, Marso SP, Pencina MJ, Cutlip DE, Mauri L, Kleiman NS, Cohen DJ; EVENT Investigators.

Circ Cardiovasc Interv. 2010 Aug;3(4):327-34. doi: 10.1161/CIRCINTERVENTIONS.110.946939. Epub 2010 Jul 6.

PMID:
20606136
11.

The impact of bivalirudin on percutaneous coronary intervention-related bleeding.

Lindsey JB, Cohen DJ, Stolker JM, Meht SK, Mahoney E, Robertus K, House JA, Kennedy K, Riggs L, Rao SV, Marso SP.

EuroIntervention. 2010 Jun;6(2):206-13. doi: 10.4244/.

PMID:
20562070
12.

Incomplete stent apposition: should we appose or oppose?

Lindsey JB, Marso SP.

JACC Cardiovasc Interv. 2010 May;3(5):495-7. doi: 10.1016/j.jcin.2010.03.005. No abstract available.

13.

Transparency of appropriateness criteria.

Stolker JM, Lindsey JB, Marso SP.

J Am Coll Cardiol. 2010 Jan 19;55(3):268; author reply 268-9. doi: 10.1016/j.jacc.2009.11.023. No abstract available.

14.

Diabetes duration is associated with increased thin-cap fibroatheroma detected by intravascular ultrasound with virtual histology.

Lindsey JB, House JA, Kennedy KF, Marso SP.

Circ Cardiovasc Interv. 2009 Dec;2(6):543-8. doi: 10.1161/CIRCINTERVENTIONS.109.876672. Epub 2009 Oct 13.

PMID:
20031772
15.

Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry.

Mehta SK, Frutkin AD, Lindsey JB, House JA, Spertus JA, Rao SV, Ou FS, Roe MT, Peterson ED, Marso SP; National Cardiovascular Data Registry.

Circ Cardiovasc Interv. 2009 Jun;2(3):222-9. doi: 10.1161/CIRCINTERVENTIONS.108.846741. Epub 2009 May 8.

PMID:
20031719
16.

Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.

Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ; EVENT Registry Investigators.

JACC Cardiovasc Interv. 2009 Nov;2(11):1074-82. doi: 10.1016/j.jcin.2009.09.002.

17.

Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).

Frutkin AD, Lindsey JB, Mehta SK, House JA, Spertus JA, Cohen DJ, Rumsfeld JS, Marso SP; NCDR (National Cardiovascular Data Registry).

JACC Cardiovasc Interv. 2009 Jul;2(7):614-21. doi: 10.1016/j.jcin.2009.05.001.

18.

ST-Segment elevation acute myocardial infarction due to severe hypotension and proximal left subclavian artery stenosis in a prior coronary artery bypass graft patient.

Dimas B, Lindsey JB, Banerjee S, Brilakis ES.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):191-4. doi: 10.1016/j.carrev.2008.08.003.

PMID:
19595403
19.

Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study.

Patel MJ, de Lemos JA, McGuire DK, See R, Lindsey JB, Murphy SA, Grundy SM, Khera A.

Am Heart J. 2009 Jun;157(6):1001-9. doi: 10.1016/j.ahj.2009.03.018.

20.

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

Lindsey JB, de Lemos JA, Cipollone F, Ayers CR, Rohatgi A, Morrow DA, Khera A, McGuire DK.

Diabetes Care. 2009 Jul;32(7):1218-20. doi: 10.2337/dc09-0053. Epub 2009 Apr 14.

21.

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

Lindsey JB, Cipollone F, Abdullah SM, McGuire DK.

Diab Vasc Dis Res. 2009 Jan;6(1):7-14. doi: 10.3132/dvdr.2009.002. Review.

PMID:
19156622
22.

Steatosis and diastolic dysfunction: the skinny on myocardial fat.

Lindsey JB, Marso SP.

J Am Coll Cardiol. 2008 Nov 25;52(22):1800-2. doi: 10.1016/j.jacc.2008.08.038. No abstract available.

23.

Independent associations between metabolic syndrome, diabetes mellitus and atherosclerosis: observations from the Dallas Heart Study.

Chen K, Lindsey JB, Khera A, De Lemos JA, Ayers CR, Goyal A, Vega GL, Murphy SA, Grundy SM, McGuire DK.

Diab Vasc Dis Res. 2008 Jun;5(2):96-101. doi: 10.3132/dvdr.2008.016.

PMID:
18537096
24.

Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study.

See R, Lindsey JB, Patel MJ, Ayers CR, Khera A, McGuire DK, Grundy SM, de Lemos JA.

Arch Intern Med. 2008 May 26;168(10):1055-62. doi: 10.1001/archinte.168.10.1055.

PMID:
18504333
25.
26.

Two "buddies" may be better than one: use of two buddy wires to expand an underexpanded left main coronary stent.

Lindsey JB, Banerjee S, Brilakis ES.

J Invasive Cardiol. 2007 Dec;19(12):E355-8.

PMID:
18180526
27.

The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study.

See R, Abdullah SM, McGuire DK, Khera A, Patel MJ, Lindsey JB, Grundy SM, de Lemos JA.

J Am Coll Cardiol. 2007 Aug 21;50(8):752-9. Epub 2007 Aug 6.

28.

Clinical update: atrial septal defect in adults.

Lindsey JB, Hillis LD.

Lancet. 2007 Apr 14;369(9569):1244-1246. doi: 10.1016/S0140-6736(07)60576-5. No abstract available.

PMID:
17434386
29.

Incidence and control of subclinical mastitis in intensively managed ewes.

McCarthy FD, Lindsey JB, Gore MT, Notter DR.

J Anim Sci. 1988 Nov;66(11):2715-21.

PMID:
3225234
30.

Efficacy of cambendazole against naturally occurring Nematodirus helvetianus and Cooperia oncophora infections in calves.

Kistner TP, Lindsey JB.

Am J Vet Res. 1974 Nov;35(11):1405-7. No abstract available.

PMID:
4429241
31.

THE ACTION OF SODIUM HYEDRATE UPON THE COMPOSITION AND DIGESTIBILITY BILITY OF GRAIN HULLS.

Lindsey JB, Archibald JG.

Science. 1923 Mar 16;57(1472):330. No abstract available.

PMID:
17753890
32.

THE EFFECT OF SODIUM HYDRATE UPON THE DIGESTIBILITY OF GRAIN HULLS.

Lindsey JB.

Science. 1922 Feb 3;55(1414):131-2. No abstract available.

PMID:
17817608

Supplemental Content

Loading ...
Support Center